SEC Form 4 · accession 0001209191-16-122738
Eiger BioPharmaceuticals, Inc. · EIGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James P Shaffer
Officer — Chief Business Officer
Period of report
May 19, 2016
Accepted (ET)
May 23, 2016 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 19, 2016 | P | 500 | $19.52 | A | 500 | D | |
| Common Stock | May 23, 2016 | P | 745 | $19.99 | A | 1,245 | D |
Table II — derivative securities
No Table II lines on this filing.